Hepatitis C Virus and Disrupted Interferon Signaling Promote Lymphoproliferation via Type II CD95 and Interleukins

Gastroenterology

Volumn 137, Issue 1, 2009, Pages

  Machida, Keigo ^a,b,c   Tsukiyama Kohara, Kyoko ^a,d   Sekiguch, Satoshi ^a   Seike, Eiji ^e   Tóne, Shigenobu ^f   Hayashi, Yukiko ^g   Tobita, Yoshimi ^a   Kasama, Yuri ^d   Shimizu, Masumi ^h   Takahashi, Hidemi ^h   Taya, Chyoji ^a   Yonekawa, Hiromichi ^a   Tanaka, Nobuyuki ^b,h   Kohara, Michinori ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d KUMAMOTO UNIVERSITY   (Japan)

^e Self Defense Forces Central Hospital   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^h NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; CORE PROTEIN; CRE RECOMBINASE; FAS ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; PROTEIN BCL 2; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE DISRUPTION; GENETIC TRANSFORMATION; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; LOXP SITE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT TRANSFORMATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN CELL; VIRUS RESISTANCE;

EID: 67649183603     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.03.061     Document Type: Article

References (33)

1. Saito I., Miyamura T., Ohbayashi A., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87 (1990) 6547-6549
2. Simonetti R.G., Camma C., Fiorello F., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 116 (1992) 97-102
3. Ferri C., Monti M., La Civita L., et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82 (1993) 3701-3704
4. Silvestri F., Pipan C., Barillari G., et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87 (1996) 4296-4301
5. Rui L., and Goodnow C.C. Lymphoma and the control of B cell growth and differentiation. Curr Mol Med 6 (2006) 291-308
6. Dietrich C.F., Lee J.H., Herrmann G., et al. Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26 (1997) 467-472
7. Ascoli V., Lo Coco F., Artini M., et al. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 109 (1998) 600-609
8. De Vita S., De Re V., Sansonno D., et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 31 (2000) 182-189
9. Mele A., Pulsoni A., Bianco E., et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102 (2003) 996-999
10. Cohen S.B., Crawley J.B., Kahan M.C., et al. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 92 (1997) 1-5
11. Pawlotsky J.M. The nature of interferon-alpha resistance in hepatitis C virus infection. Curr Opin Infect Dis 16 (2003) 587-592
12. Levine A.M., Shimodaira S., and Lai M.M. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med 349 (2003) 2078-2079
13. Moriya K., Fujie H., Shintani Y., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4 (1998) 1065-1067
14. Lerat H., Honda M., Beard M.R., et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122 (2002) 352-365
15. Wakita T., Taya C., Katsume A., et al. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 273 (1998) 9001-9006
16. Machida K., Tsukiyama-Kohara K., Seike E., et al. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J Biol Chem 276 (2001) 12140-12146
17. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
18. Taki S., Sato T., Ogasawara K., et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6 (1997) 673-679
19. Yanagi M., Purcell R.H., Emerson S.U., et al. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 94 (1997) 8738-8743
20. Yanagi M., St Claire M., Shapiro M., et al. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 244 (1998) 161-172
21. Machida K., Cheng K.T., Pavio N., et al. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 79 (2005) 8079-8089
22. Kondo Y., Sung V.M., Machida K., et al. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 361 (2007) 161-173
23. McDonnell T.J., Deane N., Platt F.M., et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57 (1989) 79-88
24. Lacronique V., Mignon A., Fabre M., et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2 (1996) 80-86
25. Ito T., Deng X., Carr B., et al. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272 (1997) 11671-11673
26. Stern J.B., and Smith K.A. Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 233 (1986) 203-206
27. Levy Y., and Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 93 (1994) 424-428
28. Taniguchi T., Ogasawara K., Takaoka A., et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 (2001) 623-655
29. Penninger J.M., Sirard C., Mittrucker H.W., et al. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 7 (1997) 243-254
30. Lohoff M., Ferrick D., Mittrucker H.W., et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6 (1997) 681-689
31. Machida K., Cheng K.T., Sung V.M., et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101 (2004) 4262-4267
32. Machida K., Kondo Y., Huang J.Y., et al. Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J Virol 82 (2008) 6711-6720
33. Dolganiuc A., Paek E., Kodys K., et al. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135 (2008) 2119-2127